Two Sigma Investments, LP Reata Pharmaceuticals Inc Transaction History

Two Sigma Investments, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$79.22 - $105.37 $1.22 Million - $1.63 Million	-15,449 Reduced 12.4%	109,131 $11.1 Million
Q1 2023 May 15, 2023	SELL	$30.85 - $93.17 $643,654 - $1.94 Million	-20,864 Reduced 14.35%	124,580 $11.3 Million
Q4 2022 Feb 14, 2023	BUY	$22.15 - $42.11 $2.16 Million - $4.1 Million	97,329 Added 202.28%	145,444 $5.53 Million
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $933,912 - $1.76 Million	48,115 New	48,115 $1.21 Million
Q1 2022 May 16, 2022	SELL	$24.12 - $39.6 $2.46 Million - $4.04 Million	-102,002 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$25.61 - $110.96 $2.61 Million - $11.3 Million	102,002 New	102,002 $2.69 Million
Q2 2020 Aug 14, 2020	SELL	$126.3 - $176.56 $6.53 Million - $9.12 Million	-51,682 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$124.16 - $247.74 $6.42 Million - $12.8 Million	51,682 New	51,682 $7.46 Million
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $1.88 Million - $2.28 Million	-24,147 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$51.9 - $101.79 $1.25 Million - $2.46 Million	24,147 New	24,147 $2.06 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.